NCT03355482View on ClinicalTrials.gov

MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLE

PHASE2TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

April 10, 2017

Primary Completion Date

February 16, 2022

Study Completion Date

December 16, 2022

Conditions
Systemic Lupus Erythematosus Arthritis
Interventions
DRUG

Methylprednisolone

160mg IM at baseline

DRUG

Placebos

IM saline injection at baseline

Trial Locations (1)

89128

Access Health, Las Vegas

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Oklahoma Medical Research Foundation

OTHER